Multibic

Sodium hydrogen carbonate, magnesium chloride hexahydrate, sodium chloride, and calcium chloride dihydrate, the active ingredients in Multibic, are electrolytes presented as a solution for injection for intravenous and haemodialysis use. They help maintain electrolyte and acid‑base balance in patients undergoing renal replacement therapy.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and dialysis centres worldwide.

Multibic is an injectable electrolyte solution used in renal replacement and fluid management.

Chronic kidney disease undergoing haemodialysis: helps correct electrolyte disturbances and maintain acid‑base balance. Acute renal failure requiring intravenous electrolyte support: provides sodium, chloride, calcium, and magnesium to prevent hypoelectrolytemia. Peri‑operative fluid management in patients at risk of electrolyte loss: supplies essential ions to support cardiovascular stability.

Multibic may be associated with a range of adverse reactions, most of which are related to its electrolyte composition and the route of administration.

Common Side Effects: - Injection site pain or erythema. - Transient hypotension during rapid infusion. - Mild nausea or gastrointestinal discomfort.

Serious or Rare Side Effects: - Hypercalcemia leading to cardiac arrhythmias. - Hypermagnesemia causing muscle weakness or respiratory depression. - Severe electrolyte imbalance requiring urgent medical intervention. - Anaphylactic or severe hypersensitivity reaction.

When using Multibic, clinicians should observe several safety measures to minimise risks.

Assess serum electrolytes before administration: check calcium, magnesium, and sodium levels. Monitor cardiac rhythm during infusion: watch for arrhythmias related to electrolyte shifts. Adjust infusion rate in patients with heart failure: avoid fluid overload. Avoid use in patients with known hypersensitivity to any component. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Multibic can interact with other medicines that affect electrolyte balance or cardiovascular function.

Major Interactions (Avoid): - Calcium channel blockers: may exacerbate hypercalcemia. - Loop diuretics: increase risk of rapid electrolyte shifts. - Anticoagulants used in dialysis circuits: altered clotting when electrolyte composition changes.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and potassium levels. - Beta‑blockers: watch for bradycardia with electrolyte changes.